Gola R, Lachard J, Zattara H, Nerini A
Rev Stomatol Chir Maxillofac. 1979;80(3):146-51.
In spite of the considerable technical progress made over the last few years, no type of irradiation used at the present time for treating malignant tumors in the maxillofacial region can protect the patient from the always dreaded appearance of a secondary osteoradionecrosis of the maxillomandibular bones. Extablished osteoradionecrosis is not a "true" necrosis of these bones but a particularly severe osteitis which evolves in bone, which is pathological because it has been irradiated, and is surrounded by tissues which are also pathological for the same reason. Very high doses of antibiotics, comparable to those used in the treatment of osteomyelitis, mandibular resection by the endobuccal route, and the possibility of treating perimaxillomandibular tissues by reconstructive surgery, have completely transformed the prognosis of this dreaded affection, which is being increasingly prevented by daily fluoride applications applied locally.
尽管在过去几年中取得了相当大的技术进步,但目前用于治疗颌面部恶性肿瘤的任何一种放射治疗方法,都无法使患者避免出现一直令人恐惧的颌骨放射性骨坏死。已形成的放射性骨坏死并非这些骨骼的“真正”坏死,而是一种特别严重的骨炎,它在因接受过放射而病变的骨骼中发展,且被同样因放射而病变的组织所包围。与治疗骨髓炎所用剂量相当的大剂量抗生素、经口内途径进行下颌骨切除,以及通过重建手术治疗颌周组织的可能性,已经彻底改变了这种可怕病症的预后,通过局部每日应用氟化物,这种病症越来越多地得到了预防。